Mirrors of Medicine(@mirrorsmed) 's Twitter Profileg
Mirrors of Medicine

@mirrorsmed

Open, multidisciplinary platform facilitating access to unique #CME programmes w/ focus on improving clinical decision making. Both online & offline.

ID:216318767

linkhttps://ppcp.mirrorsmed.org/ calendar_today16-11-2010 11:22:34

2,1K Tweets

958 Followers

1,3K Following

Mirrors of Medicine(@mirrorsmed) 's Twitter Profile Photo

🧑‍⚕️ Gain insight into systemic therapy for early stage TNBC

📌 Check out our updated case-based course: ppcp.mirrorsmed.org/en/topic/1xfag…

Elisa Agostinetto OncoAlert

🧑‍⚕️ Gain insight into systemic therapy for early stage TNBC 📌 Check out our updated case-based #CME course: ppcp.mirrorsmed.org/en/topic/1xfag… @ElisaAgostinett @OncoAlert #PPCP #bcsm
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

An Amazing with GREAT New Data in
: Axel S. Merseburger 🇩🇪🚨
: Petros Grivas 🇺🇸🚨
:Philippe Barthélémy🇫🇷
But...HOW DOES IT TRANSLATE IN CLINICS ⁉️
Mirrors of Medicine Has your covered Just Click The Link: library.mirrorsmed.org/index.php/newd…

An Amazing #GU24 with GREAT New Data in ✅ #ProstateCancer : @amerseburger 🇩🇪🚨 ✅ #BladderCancer : @PGrivasMDPhD 🇺🇸🚨 ✅ #KidneyCancer :Philippe Barthélémy🇫🇷 But...HOW DOES IT TRANSLATE IN CLINICS ⁉️ @mirrorsmed Has your covered Just Click The Link: library.mirrorsmed.org/index.php/newd…
account_circle
Tom Powles(@tompowles1) 's Twitter Profile Photo

With a median FU up of ~5 yrs adjuvant pembro= 38% reduction in risk of death. The benefit is across subgroups (T stage etc). Subsequent therapy in 80% is relapses. The 1st +ve OS adjuvant PD1 study, making adjuvant pembro more attractive. Toni Choueiri, MD

With a median FU up of ~5 yrs adjuvant pembro= 38% reduction in risk of death. The benefit is across subgroups (T stage etc). Subsequent therapy in 80% is relapses. The 1st +ve OS adjuvant PD1 study, making adjuvant pembro more attractive. #GU24 @DrChoueiri
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The OncoAlert 🚨Round Up for DAY 2 🇺🇸


TO REGISTER go to OncoAlert360.com or
oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing
✅AMBASSADOR
✅UNITE in EV
✅FDG PET
✅ASPIRE
and more

Gil Morgan, MD
Tom Powles Amanda Nizam, MD Toni Choueiri, MD Andrea Apolo, M.D. Shilpa Gupta

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The OncoAlert 🚨Round Up for Day One of ASCO in beautiful San Francisco Focused on

To REGISTER for the Newsletter go to OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Covering:
✅CONTACT 02
✅BRCA AWAY🧬
✅FORMULA 509 ⚗️
✅GETUG 18 ☢️
✅PRESTO &…

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues attending
Our Collaborators of VJ Oncology are here in 🇺🇸 bringing you insights from TOP faculty, open-access and expert-led updates in 🗞️

For the latest in coverage Click Below‼️
vjoncology.com/event/gu-cance…

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues at 🇺🇸
Our Partners at Mirrors of Medicine are live in San Francisco bringing us great content by some of the Top experts!

You can also find these TOP experts at in Vienna 🇦🇹Nov 27-30, 2024

DISCOUNTED EARLY REGISTRATION AVAILABLE…

account_circle
Mirrors of Medicine(@mirrorsmed) 's Twitter Profile Photo

🧑‍⚕️Gain insight into systemic therapy for mRCC: second line and beyond

📌Check out our updated case-based course:
ppcp.mirrorsmed.org/en/topic/r95r1…

📽️Including a case discussion by Dr. A. Bahl and Dr. A. Challapalli

OncoAlert

🧑‍⚕️Gain insight into systemic therapy for mRCC: second line and beyond 📌Check out our updated case-based #CME course: ppcp.mirrorsmed.org/en/topic/r95r1… 📽️Including a case discussion by Dr. A. Bahl and Dr. A. Challapalli #PPCP #renalcellcarcinoma @OncoAlert
account_circle
Mirrors of Medicine(@mirrorsmed) 's Twitter Profile Photo

Check Dr. Bernadett Szabados expert opinion on Elena's case.
Interested in other clinical cases?
All case discussions from are available on library.mirrorsmed.org.
Don’t forget to save the 2024 dates: BLADDR 27-28 Nov, PROSCA 29-30 Nov, both in Vienna!

More clinical…

account_circle
Dra. María Natalia Gandur Quiroga(@nataliagandur) 's Twitter Profile Photo

🌐 Multidisciplinary young academics session: Future management of T2N0M0 Urothelial Carcinoma.

Moderators Laura Mertens & Marco Moschini. A standout presentation by Daniele Raggi—Exploring avenues for advancing drug development in MIBC through (neo)adjuvant strategies and…

🌐 Multidisciplinary young academics session: Future management of T2N0M0 Urothelial Carcinoma. Moderators Laura Mertens & @UroMoschini. A standout presentation by @DanieleRaggi83—Exploring avenues for advancing drug development in MIBC through (neo)adjuvant strategies and…
account_circle
Sara M. S.(@sarabrown92) 's Twitter Profile Photo

Great session of A new standard of care in 1st-line treatment of mUCA? 👉 Ignacio Duran great speaker 👏🏼

Maria De Santis Prof Ananya💙 Ignacio Duran Peter Hoskin Ron Jones Petros Grivas 👉
Cases & Lectures in OMBC, mUCa, targeted therapies
OncoAlert

Great session of #BLADDR23 A new standard of care in 1st-line treatment of mUCA? 👉 @nachoduranm great speaker 👏🏼 @mdesantis234 @achoud72 @nachoduranm Peter Hoskin Ron Jones @PGrivasMDPhD 👉 Cases & Lectures in OMBC, mUCa, targeted therapies @OncoAlert
account_circle